Capital Planning Advisors Upped By $377,702 Its Parker Hannifin (PH) Holding; United Therapeutics Has 1.14 Sentiment

April 24, 2018 - By Ellis Scott

Parker-Hannifin Corporation (NYSE:PH) Logo

Capital Planning Advisors Llc increased Parker Hannifin Corp (PH) stake by 10.13% reported in 2017Q4 SEC filing. Capital Planning Advisors Llc acquired 1,898 shares as Parker Hannifin Corp (PH)’s stock declined 14.50%. The Capital Planning Advisors Llc holds 20,627 shares with $4.12 million value, up from 18,729 last quarter. Parker Hannifin Corp now has $23.08B valuation. The stock increased 0.85% or $1.47 during the last trading session, reaching $173.43. About 229,196 shares traded. Parker-Hannifin Corporation (NYSE:PH) has risen 9.45% since April 24, 2017 and is uptrending. It has underperformed by 2.10% the S&P500.

United Therapeutics Corp (UTHR) investors sentiment increased to 1.14 in Q4 2017. It’s up 0.15, from 0.99 in 2017Q3. The ratio has improved, as 158 hedge funds increased and opened new stock positions, while 138 cut down and sold holdings in United Therapeutics Corp. The hedge funds in our database now possess: 40.90 million shares, down from 41.49 million shares in 2017Q3. Also, the number of hedge funds holding United Therapeutics Corp in top ten stock positions was flat from 3 to 3 for the same number . Sold All: 26 Reduced: 112 Increased: 105 New Position: 53.

Capital Planning Advisors Llc decreased Vanguard Index Fds (VTV) stake by 3,944 shares to 109,259 valued at $11.62M in 2017Q4. It also reduced Altria Group Inc (NYSE:MO) stake by 7,096 shares and now owns 39,729 shares. Celgene Corp (NASDAQ:CELG) was reduced too.

Since February 16, 2018, it had 0 insider purchases, and 3 insider sales for $780,751 activity. SCAMINACE JOSEPH sold $184,971 worth of stock. Sherrard Roger S sold $384,091 worth of stock.

Investors sentiment increased to 1.07 in Q4 2017. Its up 0.12, from 0.95 in 2017Q3. It increased, as 44 investors sold PH shares while 201 reduced holdings. 71 funds opened positions while 191 raised stakes. 100.90 million shares or 0.87% more from 100.03 million shares in 2017Q3 were reported. 2,279 were reported by Bessemer Group Inc Inc. Amf Pensionsforsakring Ab invested in 358,128 shares. Moreover, Gulf International National Bank & Trust (Uk) Limited has 0.11% invested in Parker-Hannifin Corporation (NYSE:PH) for 43,025 shares. De Burlo has 0.04% invested in Parker-Hannifin Corporation (NYSE:PH). Beaumont Finance Prtnrs Lc owns 1,235 shares or 0.03% of their US portfolio. Smith Asset Management Group Incorporated Limited Partnership stated it has 157,317 shares or 0.99% of all its holdings. Farmers Co owns 10,063 shares. Prudential Fincl Incorporated has 193,080 shares. Mai Cap accumulated 0.08% or 7,136 shares. Amica Pension Fund Board Of Trustees reported 5,062 shares. The North Carolina-based Captrust Financial Advisors has invested 0% in Parker-Hannifin Corporation (NYSE:PH). California-based United Capital Fincl Advisers Limited Liability has invested 0.1% in Parker-Hannifin Corporation (NYSE:PH). Jarislowsky Fraser Ltd has invested 0.02% in Parker-Hannifin Corporation (NYSE:PH). Virtu Limited Liability accumulated 0.04% or 4,025 shares. Shamrock Asset Limited Liability Company stated it has 206 shares.

Among 21 analysts covering Parker-Hannifin (NYSE:PH), 12 have Buy rating, 1 Sell and 8 Hold. Therefore 57% are positive. Parker-Hannifin had 84 analyst reports since August 9, 2015 according to SRatingsIntel. Jefferies maintained Parker-Hannifin Corporation (NYSE:PH) rating on Monday, September 11. Jefferies has “Hold” rating and $165.0 target. The firm has “Hold” rating given on Wednesday, January 20 by Jefferies. The rating was upgraded by JP Morgan to “Neutral” on Friday, October 9. The rating was maintained by Morgan Stanley on Thursday, March 2 with “Overweight”. The stock has “Hold” rating by Jefferies on Thursday, January 18. Stifel Nicolaus maintained it with “Buy” rating and $245.0 target in Tuesday, January 16 report. On Friday, November 3 the stock rating was maintained by Citigroup with “Neutral”. The rating was maintained by Robert W. Baird on Thursday, August 24 with “Hold”. The firm has “Sell” rating by Vertical Research given on Thursday, March 10. The stock has “Buy” rating by Stifel Nicolaus on Sunday, December 10.

Since January 1, 0001, it had 0 buys, and 10 sales for $26.79 million activity.

The stock decreased 0.39% or $0.43 during the last trading session, reaching $111.07. About 13,532 shares traded. United Therapeutics Corporation (UTHR) has declined 23.69% since April 24, 2017 and is downtrending. It has underperformed by 35.24% the S&P500.

Analysts await United Therapeutics Corporation (NASDAQ:UTHR) to report earnings on April, 25. They expect $3.51 earnings per share, down 9.77% or $0.38 from last year’s $3.89 per share. UTHR’s profit will be $151.78 million for 7.91 P/E if the $3.51 EPS becomes a reality. After $2.06 actual earnings per share reported by United Therapeutics Corporation for the previous quarter, Wall Street now forecasts 70.39% EPS growth.

Parker-Hannifin Corporation (NYSE:PH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: